On October 13th, Willingjet hosted its second online lecture about medical translation. The focus of this event was "Exploring the Principles and Applications of Advanced Translation Technologies." Willingjet's co-founder, Michael Zou, took to the virtual stage to provide in-depth insights to professionals in the life science industry. He detailed various advanced translation technologies and how they can be applied effectively within the translation field.
This presentation covered a wide array of topics, including computer-assisted translation technology, collaborative translation and review, human-computer-assisted translation, quality assurance techniques, machine translation, data analysis, and automation technologies. Mr. Zou also offered a forward-looking exploration of the potential applications of AIGC Large Language Models in the future of the translation industry.
The event garnered significant interest and participation from a diverse audience, including experts in the field of medicine and medical device, professionals from pharmaceutical companies, and translation enthusiasts. Participants actively posed questions and shared their viewpoints, making the event a resounding success. After the event, many attendees expressed their gratitude to Mr. Zou and Willingjet for their invaluable knowledge-sharing.
Michael Zou: Co-founder of Willingjet, an expert in the field of medical translation and registration. He has a strong passion for translation technology and has consistently remained at the forefront of technological advancements. Mr. Zou is known for his willingness to share his knowledge with peers in the industry.
Willingjet is a professional company in the field of medical translation, providing global multilingual services. Since its founding in 2002, the company has been dedicated to serving world-class organizations, earning widespread recognition and acclaim from its clients.
EN 
cn 
de 
jp 
